Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis.
Palazuelos J, Davoust N, Julien B, Hatterer E, Aguado T, Mechoulam R, Benito C, Romero J, Silva A, Guzmán M, Nataf S, Galve-Roperh I. Palazuelos J, et al. Among authors: julien b. J Biol Chem. 2008 May 9;283(19):13320-9. doi: 10.1074/jbc.M707960200. Epub 2008 Mar 11. J Biol Chem. 2008. PMID: 18334483 Free article.
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.
Blázquez C, Chiarlone A, Sagredo O, Aguado T, Pazos MR, Resel E, Palazuelos J, Julien B, Salazar M, Börner C, Benito C, Carrasco C, Diez-Zaera M, Paoletti P, Díaz-Hernández M, Ruiz C, Sendtner M, Lucas JJ, de Yébenes JG, Marsicano G, Monory K, Lutz B, Romero J, Alberch J, Ginés S, Kraus J, Fernández-Ruiz J, Galve-Roperh I, Guzmán M. Blázquez C, et al. Among authors: julien b. Brain. 2011 Jan;134(Pt 1):119-36. doi: 10.1093/brain/awq278. Epub 2010 Oct 7. Brain. 2011. PMID: 20929960
[The endocannabinoid system as a novel target for the treatment of liver fibrosis].
Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Hezode C, Mallat A, Lotersztajn S. Teixeira-Clerc F, et al. Among authors: julien b. Pathol Biol (Paris). 2008 Feb;56(1):36-8. doi: 10.1016/j.patbio.2007.01.001. Epub 2007 Apr 6. Pathol Biol (Paris). 2008. PMID: 17412522 Review. French.
CB2 receptors as new therapeutic targets for liver diseases.
Lotersztajn S, Teixeira-Clerc F, Julien B, Deveaux V, Ichigotani Y, Manin S, Tran-Van-Nhieu J, Karsak M, Zimmer A, Mallat A. Lotersztajn S, et al. Among authors: julien b. Br J Pharmacol. 2008 Jan;153(2):286-9. doi: 10.1038/sj.bjp.0707511. Epub 2007 Oct 22. Br J Pharmacol. 2008. PMID: 17952109 Free PMC article. Review.
Antifibrogenic role of the cannabinoid receptor CB2 in the liver.
Julien B, Grenard P, Teixeira-Clerc F, Van Nhieu JT, Li L, Karsak M, Zimmer A, Mallat A, Lotersztajn S. Julien B, et al. Gastroenterology. 2005 Mar;128(3):742-55. doi: 10.1053/j.gastro.2004.12.050. Gastroenterology. 2005. PMID: 15765409
Hepatic fibrosis: molecular mechanisms and drug targets.
Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P, Mallat A. Lotersztajn S, et al. Among authors: julien b. Annu Rev Pharmacol Toxicol. 2005;45:605-28. doi: 10.1146/annurev.pharmtox.45.120403.095906. Annu Rev Pharmacol Toxicol. 2005. PMID: 15471534 Review.
100 results